He said: "We were surprised to find that flavanoids isolated from citrus fruits were very effective at reprogramming the response of human endothelial cells to immune molecules by switching on genes that exert a natural, 'protective' effect against inflammation.

AngioPhase[TM] incorporates a patented technology, developed by TCS Cellworks Limited, Buckingham, UK, in which human endothelial cells are co-cultured with other human cells in a specially designed medium.